Thus, the effects of plasmin and plasminogen on stroke and thrombolytic therapy appeared to be multidirectional, encompassing both negative effects of plasmin and putative positive effects of plasminogen, whereas the complexity of directly measuring endogenous plasmin dynamics in rodent brain tends to complicate the analysis of these mechanisms. The gene discussed is PLG; the disease is stroke disorder.